Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders

By Holmes A.   Heilig M.   Rupniak N.M.J.   Steckler T.   Griebel G.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 11, 2003-11 ,pp. : 580-588

Elsevier

Access to resources Recommend Favorite

Gut Emotions - Mechanisms of Action of Probiotics as Novel Therapeutic Targets for Depression and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 13, Iss. 10, 2014-12 ,pp. : 1770-1786

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides in Psychiatric Diseases: An Overview with a Particular Focus on Depression and Anxiety Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 5, Iss. 2, 2006-01 ,pp. : 135-145

Bentham Science Publishers

Access to resources Recommend Favorite

Neuropeptides as Possible Targets in Sleep Disorders: Special Emphasis on Hypocretin-Deficient Narcolepsy

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 1, 2007-02 ,pp. : 45-62

Bentham Science Publishers

Access to resources Recommend Favorite

GABAergic and Endocannabinoid Dysfunction in Anxiety - Future Therapeutic Targets?

By  

Current Pharmaceutical Design, Vol. 14, Iss. 33, 2008-11 ,pp. : 3508-3517

Bentham Science Publishers

Access to resources Recommend Favorite